nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—sarcoma	0.045	1	CrCbGaD
Nitazoxanide—Blood creatinine increased—Mitoxantrone—sarcoma	0.00794	0.00831	CcSEcCtD
Nitazoxanide—Dysuria—Thiotepa—sarcoma	0.00793	0.00831	CcSEcCtD
Nitazoxanide—Lung disorder—Epirubicin—sarcoma	0.00769	0.00805	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00748	0.00783	CcSEcCtD
Nitazoxanide—Epistaxis—Thiotepa—sarcoma	0.00713	0.00747	CcSEcCtD
Nitazoxanide—Lung disorder—Doxorubicin—sarcoma	0.00712	0.00745	CcSEcCtD
Nitazoxanide—Dysuria—Vincristine—sarcoma	0.00703	0.00737	CcSEcCtD
Nitazoxanide—Pharyngitis—Dactinomycin—sarcoma	0.00669	0.007	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Etoposide—sarcoma	0.00622	0.00651	CcSEcCtD
Nitazoxanide—Amenorrhoea—Epirubicin—sarcoma	0.0062	0.00649	CcSEcCtD
Nitazoxanide—Chills—Thiotepa—sarcoma	0.00609	0.00638	CcSEcCtD
Nitazoxanide—Chills—Dactinomycin—sarcoma	0.00605	0.00633	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Vincristine—sarcoma	0.00599	0.00627	CcSEcCtD
Nitazoxanide—Rhinitis—Mitoxantrone—sarcoma	0.00588	0.00616	CcSEcCtD
Nitazoxanide—Pharyngitis—Mitoxantrone—sarcoma	0.00582	0.00609	CcSEcCtD
Nitazoxanide—Amenorrhoea—Doxorubicin—sarcoma	0.00573	0.006	CcSEcCtD
Nitazoxanide—Creatinine increased—Epirubicin—sarcoma	0.00572	0.00599	CcSEcCtD
Nitazoxanide—Back pain—Thiotepa—sarcoma	0.00572	0.00599	CcSEcCtD
Nitazoxanide—Anaemia—Thiotepa—sarcoma	0.00546	0.00572	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Dactinomycin—sarcoma	0.00544	0.0057	CcSEcCtD
Nitazoxanide—Anaemia—Dactinomycin—sarcoma	0.00542	0.00568	CcSEcCtD
Nitazoxanide—Creatinine increased—Doxorubicin—sarcoma	0.00529	0.00554	CcSEcCtD
Nitazoxanide—Malaise—Dactinomycin—sarcoma	0.00529	0.00554	CcSEcCtD
Nitazoxanide—Chills—Mitoxantrone—sarcoma	0.00526	0.00551	CcSEcCtD
Nitazoxanide—Hypertension—Thiotepa—sarcoma	0.0051	0.00534	CcSEcCtD
Nitazoxanide—Back pain—Vincristine—sarcoma	0.00507	0.00531	CcSEcCtD
Nitazoxanide—Myalgia—Thiotepa—sarcoma	0.00503	0.00527	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Epirubicin—sarcoma	0.005	0.00524	CcSEcCtD
Nitazoxanide—Myalgia—Dactinomycin—sarcoma	0.00499	0.00523	CcSEcCtD
Nitazoxanide—Back pain—Mitoxantrone—sarcoma	0.00494	0.00517	CcSEcCtD
Nitazoxanide—Discomfort—Dactinomycin—sarcoma	0.00493	0.00517	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Etoposide—sarcoma	0.00485	0.00508	CcSEcCtD
Nitazoxanide—Anaemia—Vincristine—sarcoma	0.00484	0.00507	CcSEcCtD
Nitazoxanide—Infection—Thiotepa—sarcoma	0.00479	0.00502	CcSEcCtD
Nitazoxanide—Oedema—Dactinomycin—sarcoma	0.00479	0.00501	CcSEcCtD
Nitazoxanide—Infection—Dactinomycin—sarcoma	0.00476	0.00498	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Mitoxantrone—sarcoma	0.00474	0.00496	CcSEcCtD
Nitazoxanide—Anaemia—Mitoxantrone—sarcoma	0.00472	0.00494	CcSEcCtD
Nitazoxanide—Tachycardia—Thiotepa—sarcoma	0.00471	0.00493	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Doxorubicin—sarcoma	0.00463	0.00485	CcSEcCtD
Nitazoxanide—Malaise—Mitoxantrone—sarcoma	0.0046	0.00482	CcSEcCtD
Nitazoxanide—Anorexia—Thiotepa—sarcoma	0.0046	0.00482	CcSEcCtD
Nitazoxanide—Anorexia—Dactinomycin—sarcoma	0.00456	0.00478	CcSEcCtD
Nitazoxanide—Hypertension—Vincristine—sarcoma	0.00453	0.00474	CcSEcCtD
Nitazoxanide—Myalgia—Vincristine—sarcoma	0.00446	0.00467	CcSEcCtD
Nitazoxanide—Hypertension—Mitoxantrone—sarcoma	0.00441	0.00461	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.0044	0.0046	CcSEcCtD
Nitazoxanide—Chills—Etoposide—sarcoma	0.00438	0.00458	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00436	0.00457	CcSEcCtD
Nitazoxanide—Myalgia—Mitoxantrone—sarcoma	0.00435	0.00455	CcSEcCtD
Nitazoxanide—Discomfort—Mitoxantrone—sarcoma	0.00429	0.0045	CcSEcCtD
Nitazoxanide—Somnolence—Thiotepa—sarcoma	0.00429	0.00449	CcSEcCtD
Nitazoxanide—Oedema—Vincristine—sarcoma	0.00428	0.00448	CcSEcCtD
Nitazoxanide—Infection—Vincristine—sarcoma	0.00425	0.00445	CcSEcCtD
Nitazoxanide—Dyspepsia—Thiotepa—sarcoma	0.00425	0.00445	CcSEcCtD
Nitazoxanide—Increased appetite—Epirubicin—sarcoma	0.00421	0.0044	CcSEcCtD
Nitazoxanide—Decreased appetite—Thiotepa—sarcoma	0.00419	0.00439	CcSEcCtD
Nitazoxanide—Oedema—Mitoxantrone—sarcoma	0.00417	0.00436	CcSEcCtD
Nitazoxanide—Decreased appetite—Dactinomycin—sarcoma	0.00416	0.00436	CcSEcCtD
Nitazoxanide—Infection—Mitoxantrone—sarcoma	0.00414	0.00433	CcSEcCtD
Nitazoxanide—Constipation—Thiotepa—sarcoma	0.00413	0.00432	CcSEcCtD
Nitazoxanide—Pain—Thiotepa—sarcoma	0.00413	0.00432	CcSEcCtD
Nitazoxanide—Back pain—Etoposide—sarcoma	0.00411	0.0043	CcSEcCtD
Nitazoxanide—Shock—Mitoxantrone—sarcoma	0.0041	0.00429	CcSEcCtD
Nitazoxanide—Pain—Dactinomycin—sarcoma	0.00409	0.00429	CcSEcCtD
Nitazoxanide—Muscle spasms—Etoposide—sarcoma	0.00408	0.00427	CcSEcCtD
Nitazoxanide—Anorexia—Vincristine—sarcoma	0.00408	0.00427	CcSEcCtD
Nitazoxanide—Tachycardia—Mitoxantrone—sarcoma	0.00407	0.00426	CcSEcCtD
Nitazoxanide—Feeling abnormal—Thiotepa—sarcoma	0.00398	0.00416	CcSEcCtD
Nitazoxanide—Anorexia—Mitoxantrone—sarcoma	0.00397	0.00416	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dactinomycin—sarcoma	0.00395	0.00413	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Thiotepa—sarcoma	0.00394	0.00413	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Etoposide—sarcoma	0.00394	0.00413	CcSEcCtD
Nitazoxanide—Anaemia—Etoposide—sarcoma	0.00392	0.00411	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00392	0.0041	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vincristine—sarcoma	0.0039	0.00408	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—sarcoma	0.00389	0.00408	CcSEcCtD
Nitazoxanide—Insomnia—Vincristine—sarcoma	0.00387	0.00405	CcSEcCtD
Nitazoxanide—Malaise—Etoposide—sarcoma	0.00383	0.00401	CcSEcCtD
Nitazoxanide—Abdominal pain—Thiotepa—sarcoma	0.00381	0.00399	CcSEcCtD
Nitazoxanide—Body temperature increased—Thiotepa—sarcoma	0.00381	0.00399	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.0038	0.00397	CcSEcCtD
Nitazoxanide—Abdominal pain—Dactinomycin—sarcoma	0.00378	0.00396	CcSEcCtD
Nitazoxanide—Body temperature increased—Dactinomycin—sarcoma	0.00378	0.00396	CcSEcCtD
Nitazoxanide—Loss of consciousness—Etoposide—sarcoma	0.00373	0.00391	CcSEcCtD
Nitazoxanide—Decreased appetite—Vincristine—sarcoma	0.00372	0.00389	CcSEcCtD
Nitazoxanide—Somnolence—Mitoxantrone—sarcoma	0.0037	0.00388	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Epirubicin—sarcoma	0.0037	0.00388	CcSEcCtD
Nitazoxanide—Dyspepsia—Mitoxantrone—sarcoma	0.00367	0.00384	CcSEcCtD
Nitazoxanide—Hypertension—Etoposide—sarcoma	0.00367	0.00384	CcSEcCtD
Nitazoxanide—Pain—Vincristine—sarcoma	0.00366	0.00383	CcSEcCtD
Nitazoxanide—Constipation—Vincristine—sarcoma	0.00366	0.00383	CcSEcCtD
Nitazoxanide—Decreased appetite—Mitoxantrone—sarcoma	0.00362	0.00379	CcSEcCtD
Nitazoxanide—Discomfort—Etoposide—sarcoma	0.00357	0.00374	CcSEcCtD
Nitazoxanide—Pain—Mitoxantrone—sarcoma	0.00356	0.00373	CcSEcCtD
Nitazoxanide—Constipation—Mitoxantrone—sarcoma	0.00356	0.00373	CcSEcCtD
Nitazoxanide—Hypersensitivity—Thiotepa—sarcoma	0.00355	0.00372	CcSEcCtD
Nitazoxanide—Hypersensitivity—Dactinomycin—sarcoma	0.00353	0.00369	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vincristine—sarcoma	0.0035	0.00366	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00349	0.00365	CcSEcCtD
Nitazoxanide—Asthenia—Thiotepa—sarcoma	0.00346	0.00362	CcSEcCtD
Nitazoxanide—Infection—Etoposide—sarcoma	0.00344	0.0036	CcSEcCtD
Nitazoxanide—Asthenia—Dactinomycin—sarcoma	0.00344	0.0036	CcSEcCtD
Nitazoxanide—Feeling abnormal—Mitoxantrone—sarcoma	0.00343	0.00359	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—sarcoma	0.00343	0.00359	CcSEcCtD
Nitazoxanide—Influenza—Epirubicin—sarcoma	0.00342	0.00358	CcSEcCtD
Nitazoxanide—Pruritus—Thiotepa—sarcoma	0.00341	0.00357	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00341	0.00357	CcSEcCtD
Nitazoxanide—Tachycardia—Etoposide—sarcoma	0.00338	0.00354	CcSEcCtD
Nitazoxanide—Abdominal pain—Vincristine—sarcoma	0.00338	0.00354	CcSEcCtD
Nitazoxanide—Body temperature increased—Vincristine—sarcoma	0.00338	0.00354	CcSEcCtD
Nitazoxanide—Anorexia—Etoposide—sarcoma	0.0033	0.00346	CcSEcCtD
Nitazoxanide—Diarrhoea—Thiotepa—sarcoma	0.0033	0.00346	CcSEcCtD
Nitazoxanide—Body temperature increased—Mitoxantrone—sarcoma	0.00329	0.00345	CcSEcCtD
Nitazoxanide—Abdominal pain—Mitoxantrone—sarcoma	0.00329	0.00345	CcSEcCtD
Nitazoxanide—Diarrhoea—Dactinomycin—sarcoma	0.00328	0.00343	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00323	0.00338	CcSEcCtD
Nitazoxanide—Dysuria—Epirubicin—sarcoma	0.00319	0.00334	CcSEcCtD
Nitazoxanide—Dizziness—Thiotepa—sarcoma	0.00319	0.00334	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—sarcoma	0.00316	0.00331	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vincristine—sarcoma	0.00315	0.0033	CcSEcCtD
Nitazoxanide—Somnolence—Etoposide—sarcoma	0.00308	0.00323	CcSEcCtD
Nitazoxanide—Hypersensitivity—Mitoxantrone—sarcoma	0.00307	0.00321	CcSEcCtD
Nitazoxanide—Asthenia—Vincristine—sarcoma	0.00307	0.00321	CcSEcCtD
Nitazoxanide—Vomiting—Thiotepa—sarcoma	0.00307	0.00321	CcSEcCtD
Nitazoxanide—Vomiting—Dactinomycin—sarcoma	0.00304	0.00319	CcSEcCtD
Nitazoxanide—Rash—Thiotepa—sarcoma	0.00304	0.00319	CcSEcCtD
Nitazoxanide—Dermatitis—Thiotepa—sarcoma	0.00304	0.00318	CcSEcCtD
Nitazoxanide—Headache—Thiotepa—sarcoma	0.00302	0.00316	CcSEcCtD
Nitazoxanide—Rash—Dactinomycin—sarcoma	0.00302	0.00316	CcSEcCtD
Nitazoxanide—Decreased appetite—Etoposide—sarcoma	0.00301	0.00315	CcSEcCtD
Nitazoxanide—Asthenia—Mitoxantrone—sarcoma	0.00299	0.00313	CcSEcCtD
Nitazoxanide—Pain—Etoposide—sarcoma	0.00296	0.0031	CcSEcCtD
Nitazoxanide—Constipation—Etoposide—sarcoma	0.00296	0.0031	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—sarcoma	0.00296	0.00309	CcSEcCtD
Nitazoxanide—Diarrhoea—Vincristine—sarcoma	0.00293	0.00306	CcSEcCtD
Nitazoxanide—Epistaxis—Epirubicin—sarcoma	0.00287	0.00301	CcSEcCtD
Nitazoxanide—Nausea—Thiotepa—sarcoma	0.00287	0.003	CcSEcCtD
Nitazoxanide—Feeling abnormal—Etoposide—sarcoma	0.00286	0.00299	CcSEcCtD
Nitazoxanide—Diarrhoea—Mitoxantrone—sarcoma	0.00285	0.00298	CcSEcCtD
Nitazoxanide—Nausea—Dactinomycin—sarcoma	0.00284	0.00298	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Etoposide—sarcoma	0.00283	0.00297	CcSEcCtD
Nitazoxanide—Dizziness—Vincristine—sarcoma	0.00283	0.00296	CcSEcCtD
Nitazoxanide—Rhinitis—Epirubicin—sarcoma	0.00274	0.00287	CcSEcCtD
Nitazoxanide—Abdominal pain—Etoposide—sarcoma	0.00274	0.00287	CcSEcCtD
Nitazoxanide—Body temperature increased—Etoposide—sarcoma	0.00274	0.00287	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Epirubicin—sarcoma	0.00272	0.00285	CcSEcCtD
Nitazoxanide—Vomiting—Vincristine—sarcoma	0.00272	0.00285	CcSEcCtD
Nitazoxanide—Pharyngitis—Epirubicin—sarcoma	0.00271	0.00284	CcSEcCtD
Nitazoxanide—Rash—Vincristine—sarcoma	0.0027	0.00282	CcSEcCtD
Nitazoxanide—Dermatitis—Vincristine—sarcoma	0.00269	0.00282	CcSEcCtD
Nitazoxanide—Headache—Vincristine—sarcoma	0.00268	0.00281	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—sarcoma	0.00266	0.00278	CcSEcCtD
Nitazoxanide—Vomiting—Mitoxantrone—sarcoma	0.00265	0.00277	CcSEcCtD
Nitazoxanide—Rash—Mitoxantrone—sarcoma	0.00263	0.00275	CcSEcCtD
Nitazoxanide—Dermatitis—Mitoxantrone—sarcoma	0.00262	0.00275	CcSEcCtD
Nitazoxanide—Headache—Mitoxantrone—sarcoma	0.00261	0.00273	CcSEcCtD
Nitazoxanide—Hypersensitivity—Etoposide—sarcoma	0.00255	0.00267	CcSEcCtD
Nitazoxanide—Nausea—Vincristine—sarcoma	0.00254	0.00266	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—sarcoma	0.00254	0.00266	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—sarcoma	0.00252	0.00264	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—sarcoma	0.00251	0.00263	CcSEcCtD
Nitazoxanide—Asthenia—Etoposide—sarcoma	0.00249	0.0026	CcSEcCtD
Nitazoxanide—Nausea—Mitoxantrone—sarcoma	0.00247	0.00259	CcSEcCtD
Nitazoxanide—Chills—Epirubicin—sarcoma	0.00245	0.00257	CcSEcCtD
Nitazoxanide—Pruritus—Etoposide—sarcoma	0.00245	0.00257	CcSEcCtD
Nitazoxanide—Diarrhoea—Etoposide—sarcoma	0.00237	0.00248	CcSEcCtD
Nitazoxanide—Flatulence—Epirubicin—sarcoma	0.00235	0.00246	CcSEcCtD
Nitazoxanide—Back pain—Epirubicin—sarcoma	0.0023	0.00241	CcSEcCtD
Nitazoxanide—Dizziness—Etoposide—sarcoma	0.00229	0.0024	CcSEcCtD
Nitazoxanide—Muscle spasms—Epirubicin—sarcoma	0.00229	0.0024	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—sarcoma	0.00227	0.00238	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Epirubicin—sarcoma	0.00221	0.00231	CcSEcCtD
Nitazoxanide—Vomiting—Etoposide—sarcoma	0.0022	0.00231	CcSEcCtD
Nitazoxanide—Anaemia—Epirubicin—sarcoma	0.0022	0.0023	CcSEcCtD
Nitazoxanide—Rash—Etoposide—sarcoma	0.00218	0.00229	CcSEcCtD
Nitazoxanide—Dermatitis—Etoposide—sarcoma	0.00218	0.00229	CcSEcCtD
Nitazoxanide—Headache—Etoposide—sarcoma	0.00217	0.00227	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—sarcoma	0.00217	0.00227	CcSEcCtD
Nitazoxanide—Malaise—Epirubicin—sarcoma	0.00215	0.00225	CcSEcCtD
Nitazoxanide—Syncope—Epirubicin—sarcoma	0.00213	0.00223	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—sarcoma	0.00213	0.00223	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—sarcoma	0.00212	0.00222	CcSEcCtD
Nitazoxanide—Loss of consciousness—Epirubicin—sarcoma	0.00209	0.00219	CcSEcCtD
Nitazoxanide—Nausea—Etoposide—sarcoma	0.00206	0.00216	CcSEcCtD
Nitazoxanide—Hypertension—Epirubicin—sarcoma	0.00205	0.00215	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—sarcoma	0.00204	0.00214	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—sarcoma	0.00204	0.00213	CcSEcCtD
Nitazoxanide—Myalgia—Epirubicin—sarcoma	0.00203	0.00212	CcSEcCtD
Nitazoxanide—Discomfort—Epirubicin—sarcoma	0.002	0.0021	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—sarcoma	0.00199	0.00208	CcSEcCtD
Nitazoxanide—Dry mouth—Epirubicin—sarcoma	0.00198	0.00208	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—sarcoma	0.00197	0.00207	CcSEcCtD
Nitazoxanide—Oedema—Epirubicin—sarcoma	0.00194	0.00203	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—sarcoma	0.00194	0.00203	CcSEcCtD
Nitazoxanide—Infection—Epirubicin—sarcoma	0.00193	0.00202	CcSEcCtD
Nitazoxanide—Shock—Epirubicin—sarcoma	0.00191	0.002	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—sarcoma	0.0019	0.00199	CcSEcCtD
Nitazoxanide—Tachycardia—Epirubicin—sarcoma	0.0019	0.00199	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—sarcoma	0.00187	0.00196	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—sarcoma	0.00185	0.00194	CcSEcCtD
Nitazoxanide—Anorexia—Epirubicin—sarcoma	0.00185	0.00194	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—sarcoma	0.00183	0.00192	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—sarcoma	0.0018	0.00188	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—sarcoma	0.00179	0.00187	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00177	0.00185	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—sarcoma	0.00177	0.00185	CcSEcCtD
Nitazoxanide—Insomnia—Epirubicin—sarcoma	0.00176	0.00184	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—sarcoma	0.00175	0.00184	CcSEcCtD
Nitazoxanide—Somnolence—Epirubicin—sarcoma	0.00173	0.00181	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—sarcoma	0.00171	0.00179	CcSEcCtD
Nitazoxanide—Dyspepsia—Epirubicin—sarcoma	0.00171	0.00179	CcSEcCtD
Nitazoxanide—Decreased appetite—Epirubicin—sarcoma	0.00169	0.00177	CcSEcCtD
Nitazoxanide—Constipation—Epirubicin—sarcoma	0.00166	0.00174	CcSEcCtD
Nitazoxanide—Pain—Epirubicin—sarcoma	0.00166	0.00174	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00164	0.00171	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—sarcoma	0.00163	0.0017	CcSEcCtD
Nitazoxanide—Feeling abnormal—Epirubicin—sarcoma	0.0016	0.00168	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—sarcoma	0.0016	0.00167	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Epirubicin—sarcoma	0.00159	0.00166	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—sarcoma	0.00158	0.00166	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—sarcoma	0.00156	0.00164	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—sarcoma	0.00154	0.00161	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—sarcoma	0.00154	0.00161	CcSEcCtD
Nitazoxanide—Abdominal pain—Epirubicin—sarcoma	0.00154	0.00161	CcSEcCtD
Nitazoxanide—Body temperature increased—Epirubicin—sarcoma	0.00154	0.00161	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—sarcoma	0.00148	0.00155	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—sarcoma	0.00147	0.00154	CcSEcCtD
Nitazoxanide—Hypersensitivity—Epirubicin—sarcoma	0.00143	0.0015	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—sarcoma	0.00142	0.00149	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—sarcoma	0.00142	0.00149	CcSEcCtD
Nitazoxanide—Asthenia—Epirubicin—sarcoma	0.00139	0.00146	CcSEcCtD
Nitazoxanide—Pruritus—Epirubicin—sarcoma	0.00137	0.00144	CcSEcCtD
Nitazoxanide—Diarrhoea—Epirubicin—sarcoma	0.00133	0.00139	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—sarcoma	0.00132	0.00139	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—sarcoma	0.00129	0.00135	CcSEcCtD
Nitazoxanide—Dizziness—Epirubicin—sarcoma	0.00128	0.00135	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—sarcoma	0.00127	0.00133	CcSEcCtD
Nitazoxanide—Vomiting—Epirubicin—sarcoma	0.00124	0.00129	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—sarcoma	0.00123	0.00129	CcSEcCtD
Nitazoxanide—Rash—Epirubicin—sarcoma	0.00122	0.00128	CcSEcCtD
Nitazoxanide—Dermatitis—Epirubicin—sarcoma	0.00122	0.00128	CcSEcCtD
Nitazoxanide—Headache—Epirubicin—sarcoma	0.00122	0.00127	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—sarcoma	0.00119	0.00124	CcSEcCtD
Nitazoxanide—Nausea—Epirubicin—sarcoma	0.00115	0.00121	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—sarcoma	0.00114	0.0012	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—sarcoma	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—sarcoma	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—sarcoma	0.00113	0.00118	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—sarcoma	0.00107	0.00112	CcSEcCtD
